InsidersTradesSigma
Track the Panacea Life Sciences Holdings, INC. stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Operating in the Health Care sector, Panacea Life Sciences Holdings, INC. has logged 16 insider filings. Market capitalisation: €1.6m. The latest transaction was filed on 20 September 2023 (Acquisition). Among the most active insiders: Buttorff Leslie. All data is openly available.
16
Insider Decl.
n/a
Thresholds
€21,951
15 ops.
Buy Volume
n/a
n/a
Sell Volume
50Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 20 September 2023
Declarations16 total
20,000 shares@ US$0.23651.2% of flowCommon StockSEC:0001493152-23-033155:0
Canonical exit: 17 Dec 2023 (T+90)
760,000 shares@ US$0.5094.3% of flowCommon StockSEC:0001493152-23-020928:0
4,500 shares@ US$0.510.6% of flowCommon StockSEC:0001493152-23-018753:0
Canonical exit: 17 Aug 2023 (T+90)
11,500 shares@ US$0.491.4% of flowCommon StockSEC:0001493152-23-016009:0
Canonical exit: 3 Aug 2023 (T+90)
1,000 shares@ US$0.320.1% of flowCommon StockSEC:0001493152-23-013730:0
Canonical exit: 24 Jul 2023 (T+90)
1,000 shares@ US$0.360.1% of flowCommon StockSEC:0001493152-23-011314:0
Canonical exit: 2 Jul 2023 (T+90)
1,000 shares@ US$0.190.0% of flowCommon StockSEC:0001493152-23-006398:0
Canonical exit: 27 May 2023 (T+90)
11,500 shares@ US$0.13780.4% of flowCommon StockSEC:0001493152-22-024273:0
Canonical exit: 24 Nov 2022 (T+90)
5,000 shares@ US$0.129100.0% of flowCommon StockSEC:0001493152-22-022609:0
Canonical exit: 9 Nov 2022 (T+90)
1,000 shares@ US$0.09550.0% of flowCommon StockSEC:0001493152-22-021447:0
Canonical exit: 1 Nov 2022 (T+90)
1,600 shares@ US$0.200.1% of flowCommon StockSEC:0001493152-22-019076:0
Canonical exit: 6 Oct 2022 (T+90)
2,500 shares@ US$0.1550.1% of flowCommon StockSEC:0001493152-22-019076:1
Canonical exit: 6 Oct 2022 (T+90)
1,000 shares@ US$0.39390.1% of flowCommon StockSEC:0001493152-22-019076:2
Canonical exit: 9 Oct 2022 (T+90)
500 shares@ US$0.4950.1% of flowCommon StockSEC:0001493152-22-019076:3
Canonical exit: 9 Oct 2022 (T+90)
2,100 shares@ US$0.39790.2% of flowCommon StockSEC:0001493152-22-019076:4
Canonical exit: 9 Oct 2022 (T+90)
11,000 shares@ US$0.500.84% mcap100.0% of flowCommon StockSEC:0001493152-22-009276:0
Canonical exit: 3 Jul 2022 (T+90)
16 of 16 declarations
About Panacea Life Sciences Holdings, INC.
Panacea Life Sciences Holdings, INC. is a company focused on the health and pharmaceutical sector. It specializes in the development of cannabinoid-based products and innovative health solutions.